Viewing Study NCT01309633


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2025-12-30 @ 3:26 PM
Study NCT ID: NCT01309633
Status: COMPLETED
Last Update Posted: 2019-07-22
First Post: 2011-03-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)
Sponsor: National University Hospital, Singapore
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module